IPMC 2025 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
3rd Edition of International Precision Medicine Conference
March 13-15, 2025
Theragnosis
Theragnosis is a patient-management technique that combines diagnosis and treatment. Theragnosis integrates the domains of tumor diagnosis and therapy in oncology in order to improve upon existing procedures. The prospects for diagnosing disease, directing treatment, and monitoring outcomes bring up a new chapter in precision medicine. To develop efficient new targeted therapies with adequate benefit/risk to patients and a better molecular understanding of how to optimise drug selection, theragnostic encompasses a wide range of subjects, including personalised medicine, pharmacogenomics, and molecular imaging. The imaging agents and medications must be administered efficiently for successful theragnosis applications, resulting in appropriate imaging signal or drug concentration in the targeted disease location.
- Nanotheragnostic probes
- Theragnostic
- Theragnosis application
Alain Chapel
Institute Of Radiological Protection And Nuclear Safety, France
Sergio Marchini
Humanitas Research Hospital, Italy
Michael Thompson
University of Toronto, CanadaSubmit your abstract Today
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Potential serum biomarkers for early detection of diabetic nephropathy
Tarek Kamal Motawi , Cairo University, Egypt
Title : Personalized & Precision Medicine (PPM) as a Unique Avenue to have the Healthcare Model Renewed to Secure the National Biosafety: Through The View of Obesity Nutrition to Reach the Personalized Diet Harmony and Lifestyle Wellness
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) thought The View of Reproductive Healthcare and Natural Family Planning: An Option for clinicians and caregivers realize the potential of genomics-informed care to secure the Individualized Human Biosafety
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : 3D Bioprinting complicated large organs with a vascular system
Vyacheslav R Shulunov, Russian Academy of Science, Russian Federation
Title : Persian medicine, medicine based on temperament
Mehdi Zarvandi, Golestan University of Medical Sciences, Iran (Islamic Republic of)